Related Experiment Video
Updated: Jul 15, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
13.1K
Application of PROTACs in Target Identification and Target Validation
Yang Liu1, Jing Liang1, Rui Zhu1
1Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Acta Materia Medica
|October 7, 2024
Summary
Proteolysis-targeting chimeras (PROTACs) are emerging as powerful tools for drug discovery. This review details their progress in target identification and validation, highlighting their potential in medicine.
Area of Science:
- Chemical Biology
- Drug Discovery
- Molecular Pharmacology
Background:
- Proteolysis-targeting chimeras (PROTACs) are a novel therapeutic modality.
- PROTACs offer unique mechanisms for protein degradation and dynamic regulation.
- Their development has significant implications for the pharmaceutical industry and academic research.
Purpose of the Study:
- To review the advancements of PROTAC technology in drug discovery.
- To differentiate the concepts of target identification and target validation.
- To summarize PROTAC applications in basic medical sciences.
Main Methods:
- Literature review of PROTAC technology.
- Analysis of PROTAC applications in target identification.
- Analysis of PROTAC applications in target validation.
Main Results:
- PROTACs are increasingly vital for target identification and validation.
- The review clarifies the distinct roles of PROTACs in these processes.
- PROTAC technology shows significant progress and broad applicability.
Conclusions:
- PROTACs are essential tools for modern drug discovery.
- Understanding PROTACs' role in target identification and validation is crucial.
- Further application of PROTACs will accelerate biomedical research.
